1. Infinity Pharmaceuticals, Inc. (20 from 108 patents)

2. Millennium Pharmaceuticals Limited (11 from 850 patents)

3. Sanofi-a Ventis Deutschland Gmbh (2 from 1,830 patents)

4. Infinity Discovery, Inc. (2 from 12 patents)

5. Proscript, Inc. (2 from 4 patents)

6. Other (1 from 832,880 patents)

7. The United States of America, As Represented by the Secretary, Department of Health and Human Services (1 from 3,539 patents)

8. Aventis Pharma Deutschland, Gmbh (1 from 330 patents)

9. Leukosite, Inc. (1 from 5 patents)

10. Elicio Therapeutics, Inc. (1 from 4 patents)

11. Millennium Pharmacueticals, Inc. (1 from 2 patents)

1. 12138301 - Compounds including a mutant KRAS sequence and a lipid and uses thereof

2. 9248124 - Use of inhibitors of IκB kinase for the treatment of cancer

3. 9108989 - Inhibitors of fatty acid amide hydrolase

4. 8703755 - Analogs of benzoquinone-containing ansamycins and methods of use thereof

5. 8629125 - Inhibitors of fatty acid amide hydrolase

6. 8378099 - Boronic ester and acid compounds, synthesis and uses

7. 8349814 - Inhibitors of fatty acid amide hydrolase

8. 8329675 - Inhibitors of fatty acid amide hydrolase

9. 8252779 - Analogs of benzoquinone-containing ansamycins and methods of use thereof

10. 8236956 - Cyclopamine analogues and methods of use thereof

11. 8003634 - Analogs of benzoquinone-containing ansamycins and methods of use thereof

12. 8003791 - Boronic ester and acid compounds, synthesis and uses

13. 7947663 - Inhibitors of fatty acid amide hydrolase

14. 7875628 - Cyclopamine analogues and methods of use thereof

15. 7833997 - Analogs of benzoquinone-containing ansamycins and methods of use thereof